The neuronal pentraxin II gene (NPTX2) inhibit proliferation and invasion of pancreatic cancer cells in vitro

Molecular Biology Reports

Volumn 38, Issue 8, 2011, Pages 4903-4911

  Zhang, Ling ^a   Gao, Jun ^a   Li, Lei ^a   Li, Zhaoshen ^a   Du, Yiqi ^a   Gong, Yanfang ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cell cycle; NPTX2; Pancreatic cancer; Tumor suppressor

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; COMPLEMENTARY DNA; MESSENGER RNA;

APOPTOSIS; ARTICLE; BAX GENE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL MIGRATION; CONTROLLED STUDY; CYCLIN D1 GENE; DNA METHYLATION; GENE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; METASTASIS; NEURONAL PENTRAXIN 2 GENE; PANCREAS CANCER; PROMOTER REGION; PROTO ONCOGENE; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; C-REACTIVE PROTEIN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN; CYCLIN D1; DNA METHYLATION; DRUG COMBINATIONS; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION; LAMININ; NEOPLASM INVASIVENESS; NERVE TISSUE PROTEINS; PANCREAS; PANCREATIC NEOPLASMS; PROTEOGLYCANS; RNA TRANSPORT; RNA, MESSENGER; S PHASE; TRANSFECTION;

EID: 84855213185     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0632-y     Document Type: Article

References (30)

1. Hruban R, Iacobuzio-Donahue C, Goggins M, Wilentz RE, Kern S (2001) Molecular pathology of pancreatic cancer. Cancer J 7:251-258
2. Gao J, Li Z, Chen Z, Shao J, Zhang L, Xu G, Tu Z, Gong Y (2006) Antisense Smo under the control of the PTCH1 promoter delivered by an adenoviral vector inhibits the growth of human pancreatic cancer. Gene Ther 13:1587-1594 (Pubitemid 44688459)
3. Zhang J, Zhang X, Zhu Y, Chen Z, Xu Z, Miao Y (2010) Transcriptional regulation of human mucin gene MUC4 in pancreatic cancer cells. Mol Biol Rep 37:2797-2802
4. Kurer MA (2007) Protein and mRNA expression of tissue factor pathway inhibitor-1 (TFPI-1) in breast, pancreatic and colorectal cancer cells. Mol Biol Rep 34:221-224
5. Egger G, Liang G, Aparicio A, Jones PA (2004) Epigenetics in human disease and prospects for epigenetic therapy. Nature 429: 457-463 (Pubitemid 38715140)
6. Noyer-Weidner M, Trautner TA (1993) Methylation of DNA in prokaryotes. EXS 64:39-108
7. Colot V, Rossignol JL (1999) Eukaryotic DNA methylation as an evolutionary device. Bioessays 21:402-411 (Pubitemid 29223312)
8. Baylin SB, Herman JG (2000) DNA hypermethylation in tumori-genesis: epigenetics joins genetics. Trends Genet 16:168-174 (Pubitemid 30169152)
9. Hossain MA, Russell JC, O'Brien R, Laterra J (2004) Neuronal pentraxin 1: a novel mediator of hypoxic-ischemic injury in neonatal brain. J Neurosci 24:4187-4196 (Pubitemid 38620794)
10. Bjartmar L, Huberman AD, Ullian EM, Rentería RC, Liu X, Xu W, Prezioso J, Susman MW, Stellwagen D, Stokes CC, Cho R, Worley P, Malenka RC (2006) Neuronal pentraxins mediate synaptic refinement in the developing visual system. J Neurosci 26:6269-6281
11. Tsui CC, Copeland NG, Gilbert DJ, Jenkins NA, Barnes C, Worley PF (1996) Narp, a novel member of the pentraxin family, promotes neurite outgrowth and is dynamically regulated by neuronal activity. J Neurosci 16:2463-2478 (Pubitemid 26122671)
12. Hsu YC, Perin MS (1995) Human neuronal pentraxin II (NPTX2): conservation, genomic structure, and chromosomal localization. Genomics 28:220-227
13. Sato N, Fukushima N, Maitra A, Matsubayashi H, Yeo CJ, Cameron JL, Hruban RH, Goggins M (2003) Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. Cancer Res 63:3735-3742 (Pubitemid 36793060)
14. Matsubayashi H, Canto M, Sato N, Klein A, Abe T, Yamashita K, Yeo C, Kalloo A, Hruban R, Goggins M (2006) DNA methyla-tion alterations in the pancreatic juice of patients with suspected pancreatic disease. Cancer Res 66:1208-1217 (Pubitemid 43165992)
15. Park J, Ryu J, Lee K, Lee J, Yoon W, Lee S, Yoo J, Woo S, Lee G, Lee C, Kim Y, Yoon Y (2007) Quantitative analysis of NPTX2 hypermethylation is a promising molecular diagnostic marker for pancreatic cancer. Pancreas 35:e9-15
16. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, Danenberg PV, Laird PW (2000) MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 28:E32
17. Gao CL, Zhao DY, Qiu J, Zhang CM, Ji CB, Chen XH, Liu F, Guo XR (2009) Resistin induces rat insulinoma cell RINm5F apoptosis. Mol Biol Rep 36:1703-1708
18. Shridhar R, Zhang J, Song J, Booth BA, Kevil CG, Sotiropoulou G, Sloane BF, Keppler D (2004) Cystatin M suppresses the malignant phenotype of human MDA-MB-435S cells. Oncogene 23:10
19. Zhang L, Huang H, Wu K, Wang M, Wu B (2010) Impact of btg2 expression on proliferation and invasion of gastric cancer cells in vitro. Mol Biol Rep 37:2579-2586
20. Albo D, Tuszynski GP (2004) Thrombospondin-1 up-regulates tumor cell invasion through the urokinase plasminogen activator receptor in head and neck cancer cells. J Surg Res 120:21-26 (Pubitemid 38686526)
21. Sato N, Fukushima N, Matsubayashi H, Goggins M (2004) Identification of maspin and S100P as novel hypomethylation targets in pancreatic cancer using global gene expression profiling. Oncogene 23:1531-1538 (Pubitemid 38406515)
22. Ji L, Chena Y, Liua T, Wang ZT (2008) Involvement of Bcl-xL degradation and mitochondrial-mediated apoptotic pathway in pyrrolizidine alkaloids-induced apoptosis in hepatocytes. Toxicol Appl Pharmacol 231:393-400
23. Chang C, Zhu Y, Tang X, Tao W (2010) The anti-proliferative effects of norcantharidin on human HepG2 cells in cell culture. Mol Biol Rep
24. Saeed S, Keehn CA, Khalil FK, Morgan MB (2005) Immuno-histochemical expression of Bax and Bcl-2 in penile carcinoma. Ann Clin Lab Sci 35:91-96 (Pubitemid 40396606)
25. Miyashita T, Reed JC (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293-299
26. Santra MK, Wajapeyee N, Green MR (2009) F-box protein FBXO31 mediates cyclin D1 degradation to induce G1 arrest after DNA damage. Nature 459:722-725
27. Muller H, Lukas J, Schneider A, Warthoe P, Bartek J, Eilers M, Strauss M (1994) Cyclin D1 expression is regulated by the reti-noblastoma protein. Proc Natl Acad Sci USA 91:2945-2949 (Pubitemid 24130151)
28. Brisken C, Ayyannan A, Nguyen C, Heineman A, Reinhardt F, Tan J, Dey SK, Dotto GP, Weinberg RA (2002) IGF-2 is a mediator of prolactin-induced morphogenesis in the breast. Dev Cell 3:877-887 (Pubitemid 35460787)
29. Toyoda M, Shirato H, Nakajima K, Kojima M, Takahashi M, Kubota M, Suzuki-Migishima R, Motegi Y, Yokoyama M, Takeuchi T (2003) Jumonji downregulates cardiac cell proliferation by repressing cyclin D1 expression. Dev Cell 5:85-97 (Pubitemid 36827344)
30. Tetsu O, McCormick F (1999) Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422-426 (Pubitemid 29180374)